Form 4: Acelyrin CLO Sanam Pangali Reports Stock Transaction

Sentiment:

SEC Form 4 Filing


Acelyrin's CLO and Head of People, Sanam Pangali, reports the disposal of 921 common stock shares to cover tax obligations related to vested restricted stock units.

Summary

  • On May 15, 2024, Sanam Pangali, CLO & Head of People at Acelyrin, Inc. (SLRN), disposed of 921 shares of common stock.
  • The transaction was executed to cover the tax liability associated with the vesting of restricted stock units.
  • The price per share was $4.47.
  • Following the transaction, Pangali directly owns 74,154 shares of Acelyrin common stock.

Sentiment

Score: 5

Explanation: The Form 4 filing itself is neutral. It simply reports a transaction related to tax obligations, which is a normal part of equity compensation.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is related to tax obligations from vested equity compensation, which is a common practice.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares to cover tax obligations.

Key Dates

DateDescription
05/15/2024Date of stock transaction and vesting of restricted stock units.
05/17/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.